US Patent 10456455 Treatment of psychological trauma
Patent 10456455 was granted and assigned to Allergan, Inc. on October, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+199 characters)
Article
Patent abstract
The present specification discloses methods of treating a psychological trauma in an individual using botulinum toxins and/or a Targeted Exocytosis Modulator, and compositions thereof.
Edits on 3 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Andrew M. Blumenfeld0
Kenton B. Abel0
Edits on 28 Mar, 2023
Golden AI
Infobox
Edits on 25 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
104564550
Date of Patent
October 29, 2019
0Patent Application Number
157075110
Date Filed
September 18, 2017
0Patent Citations
Patent Citations Received
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Edits on 8 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 29 Jan, 2022
Golden AI
Edits made to:
Infobox (+11 properties)
US Patent 10456455 Treatment of psychological trauma
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10456455
Date of patent
October 29, 2019
Patent application number
15707511
Date Filed
September 18, 2017
Patent citations
Patent primary examiner
Find more entities like US Patent 10456455 Treatment of psychological trauma
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
